Cargando…

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)

BACKGROUND: Stereotactic Body Radiotherapy (SBRT) is a standard treatment for inoperable primary and secondary lung tumors. In case of ultracentral tumor location, defined as tumor contact with vulnerable mediastinal structures such as the proximal bronchial tree (PBT) or esophagus, SBRT is associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regnery, Sebastian, Ristau, Jonas, Weykamp, Fabian, Hoegen, Philipp, Sprengel, Simon David, Paul, Katharina Maria, Buchele, Carolin, Klüter, Sebastian, Rippke, Carolin, Renkamp, Claudia Katharina, Pohl, Moritz, Meis, Jan, Welzel, Thomas, Adeberg, Sebastian, Koerber, Stefan Alexander, Debus, Jürgen, Hörner-Rieber, Juliane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134672/ https://www.ncbi.nlm.nih.gov/pubmed/35614486 http://dx.doi.org/10.1186/s13014-022-02070-x

Ejemplares similares

Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022)

Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
por: Regnery, Sebastian, et al.
Publicado: (2023)

Quality assurance for on‐table adaptive magnetic resonance guided radiation therapy: A software tool to complement secondary dose calculation and failure modes discovered in clinical routine
por: Rippke, Carolin, et al.
Publicado: (2022)

Leaf-individual calibration for a double stack multileaf collimator in photon radiotherapy
por: Rippke, Carolin, et al.
Publicado: (2023)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
por: Hoegen, P., et al.
Publicado: (2022)

A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy
por: Klüter, Sebastian, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool
por: Weykamp, Fabian, et al.
Publicado: (2020)

First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany
por: Klüter, Sebastian, et al.
Publicado: (2020)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
por: Ristau, J., et al.
Publicado: (2022)

MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?
por: Hörner-Rieber, Juliane, et al.
Publicado: (2021)

Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
por: Forster, Tobias, et al.
Publicado: (2020)

Nie wieder postoperative Radiotherapie in der pN2-Situation nach kompletter Resektion des nichtkleinzelligen Bronchialkarzinoms? Eine strahlentherapeutische Interpretation des Lung ART Trial
por: Weykamp, Fabian, et al.
Publicado: (2022)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2020)

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)

Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective Analysis
por: Dinges, Lisa-Antonia, et al.
Publicado: (2022)

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial
por: Held, Thomas, et al.
Publicado: (2022)

Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
por: Küchler, Maike, et al.
Publicado: (2022)

Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response
por: El Shafie, Rami A., et al.
Publicado: (2019)

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?
por: Adeberg, Sebastian, et al.
Publicado: (2014)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial
por: Regnery, Sebastian, et al.
Publicado: (2023)

Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial
por: Regnery, Sebastian, et al.
Publicado: (2023)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
por: Hoeltgen, Line, et al.
Publicado: (2023)

Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
por: Seidensaal, Katharina, et al.
Publicado: (2022)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates
por: Eichkorn, Tanja, et al.
Publicado: (2020)

Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer
por: Meixner, Eva, et al.
Publicado: (2022)

Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT
por: Dendl, Katharina, et al.
Publicado: (2021)

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
por: Windisch, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k537rejuj05bpko9uvhogjrrvc